Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

Meet our Council Members: Derek Foster, ethical and responsible leadership role model
2016-05-18

Description: 2016 05 18 Derek Foster Tags: 2016 05 18 Derek FosterMr Derek Foster
Photo: Stephen Collett

Derek Foster was elected to the Council of the University of the Free State (UFS) in October 2012. He was the first Chartered Accountant (South Africa) to be appointed to Council because of the role he could play through his training, background, and experience. In particular, it was his knowledge of corporate governance, ethics, and reporting that led to his serving currently on the Audit and Risk Committee, the Finance Committee, and the Investment Committee of Council.

This Kovsie alumnus qualified as chartered accountant at the UFS in 1978. During his student years, he played rugby for Oud-Studente, and served in the Evening Student Representative Council.

Until December 2010, Derek was a partner in PricewaterhouseCoopers, which he joined in 1972 as a rookie when the company was still known as Meyer, Nel and Co. Nowadays, he is a business consultant and company director, serving on the boards of NWK Limited, Cancer Association of South Africa (national), and Samba Cooperative Limited.

His background and knowledge of auditing shine through strongly when it comes to the manner in which he sees his role as Council member. “The contribution which I can make to the Council of the university is to ensure that management executes strategy and policy appropriately, as formulated and approved by Council, in the best interest of the university community. Of course, this should be done in an ethical, sustainable manner, taking into account the risk environment we find ourselves in. We need to provide ethical leadership, and ensure that the UFS is a responsible corporate institution,” he says.

Work obligations are keeping him very busy, but his four grandsons are equally high on his priority list. He met his wife, Sally, at Kovsies, another reason why the university is close to his heart. “Everything I do, I want to do with enthusiasm and passion, and I want to make a difference wherever I go. I would also like to be a good grandfather, and set a memorable example to my grandchildren,” he says.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept